Abbott Laboratories vs. Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
ABT
Abbott Laboratories
$109.93 -3.23%
VS KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares
$96.12 +3.03%
Abbott Laboratories and Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | KNSA | |
|---|---|---|
| Market Cap | $190.39 billion | $7.33 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | KNSA | |
|---|---|---|
| Dividend Yield | 2.29% | — |
ABT and KNSA split the dividend factors evenly.
Risk & Sentiment
| ABT | KNSA | |
|---|---|---|
| Short Interest | 0.57% | 0.02% |
KNSA leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, KNSA overview, KNSA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.